Editorial: Liquid Biopsy as a Tool for Precision Oncology: New Challenges to Assess Clinical Response

Gloria Ravegnini, Marzia Del Re, Ambra A. Grolla, Ron H.N. van Schaik, Sabrina Angelini

Research output: Contribution to journalEditorial

Original languageEnglish
Article number598261
JournalFrontiers in Pharmacology
Volume11
DOIs
Publication statusPublished - 7 Oct 2020

Keywords

  • Circulating molecular marker
  • ctDNA (circulating tumor DNA)
  • liquid biopsy
  • personalized medicine
  • precision oncology

Cite this